KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $4.8 billion.

  • Bristol Myers Squibb's Other Operating Expenses fell 1822.84% to $4.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.2 billion, marking a year-over-year decrease of 3743.17%. This contributed to the annual value of $37.1 billion for FY2024, which is 9033.6% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Other Operating Expenses is $4.8 billion, which was down 1822.84% from $6.2 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Other Operating Expenses peaked at $18.3 billion during Q1 2024, and registered a low of $4.4 billion during Q1 2025.
  • Over the past 5 years, Bristol Myers Squibb's median Other Operating Expenses value was $5.3 billion (recorded in 2023), while the average stood at $6.0 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Other Operating Expenses skyrocketed by 30854.15% in 2024 and then crashed by 7604.13% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Other Operating Expenses stood at $5.3 billion in 2021, then dropped by 9.21% to $4.8 billion in 2022, then increased by 10.08% to $5.3 billion in 2023, then soared by 30.24% to $6.8 billion in 2024, then dropped by 29.96% to $4.8 billion in 2025.
  • Its last three reported values are $4.8 billion in Q3 2025, $6.2 billion for Q2 2025, and $4.4 billion during Q1 2025.